About HeartFlow
HeartFlow is a company based in Redwood City (United States) founded in 2007.. HeartFlow has raised $936.05 million across 12 funding rounds from investors including Fidelity Investments, Hayfin and HHS. HeartFlow offers products and services including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis. HeartFlow operates in a competitive market with competitors including Change Healthcare, AIdoc, Cleerly, Median and AI Medical Service, among others.
- Headquarter Redwood City, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Heartflow, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$936.05 M (USD)
in 12 rounds
-
Latest Funding Round
$98.36 M (USD), Series F
Mar 27, 2025
-
Investors
Fidelity Investments
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HeartFlow
HeartFlow is a publicly listed company on the NASDAQ with ticker symbol HTFL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of HeartFlow
HeartFlow offers a comprehensive portfolio of products and services, including Roadmap Analysis, FFR CT Analysis, and Plaque Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Efficiently detects coronary artery disease from CCTA scans.
Assesses blood flow in coronary arteries for treatment decisions.
Quantifies and characterizes plaque to inform disease risk management.
Unlock access to complete
Unlock access to complete
Funding Insights of HeartFlow
HeartFlow has successfully raised a total of $936.05M across 12 strategic funding rounds. The most recent funding activity was a Series F round of $98.36 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series F — $98.4M
-
First Round
First Round
(02 Jul 2009)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series F - HeartFlow | Valuation |
investors |
|
| Mar, 2023 | Amount | Series F - HeartFlow | Valuation | Bain Capital Life Sciences | |
| Jun, 2019 | Amount | Series E - HeartFlow | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HeartFlow
HeartFlow has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Hayfin and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Private debt investments are directed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HeartFlow
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HeartFlow
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Heartflow Comparisons
Competitors of HeartFlow
HeartFlow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, Cleerly, Median and AI Medical Service, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| domain | founded_year | HQ Location |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| domain | founded_year | HQ Location |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| domain | founded_year | HQ Location |
Medical imaging software and services are provided for clinical trials.
|
|
| domain | founded_year | HQ Location |
Provider of AI-based solution for diagnosis of cancer related lesions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Heartflow
Frequently Asked Questions about HeartFlow
When was HeartFlow founded?
HeartFlow was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is HeartFlow located?
HeartFlow is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of HeartFlow?
John Farquhar is the current CEO of HeartFlow.
Is HeartFlow a funded company?
HeartFlow is a funded company, having raised a total of $936.05M across 12 funding rounds to date. The company's 1st funding round was a Series E of $65M, raised on Jul 02, 2009.
What does HeartFlow do?
HeartFlow was founded in 2007 and is based in Redwood City, United States. Operations focus on the cardiovascular sector, where CT scans and high-performance computing are utilized to analyze blood flow in coronary arteries. Data is supplied to physicians for diagnostic purposes, with studies indicating enhanced accuracy over standard CT scans alone. Services support clinical decision-making in heart disease assessment.
Who are the top competitors of HeartFlow?
HeartFlow's top competitors include Change Healthcare, AIdoc and eCential Robotics.
What products or services does HeartFlow offer?
HeartFlow offers Roadmap Analysis, FFR CT Analysis, and Plaque Analysis.
Is HeartFlow publicly traded?
Yes, HeartFlow is publicly traded on NASDAQ under the ticker symbol HTFL.
Who are HeartFlow's investors?
HeartFlow has 12 investors. Key investors include Fidelity Investments, Hayfin, HHS, Baillie Gifford, and Janus Henderson Investors.
What is HeartFlow's ticker symbol?
The ticker symbol of HeartFlow is HTFL on NASDAQ.
What is HeartFlow's valuation?
The valuation of HeartFlow is $1.3B as of Jun 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.